RMP-A03 Ocular Suspension in Patients With Pterygium
NCT05794204
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
77
Enrollment
INDUSTRY
Sponsor class
Conditions
Pterygium
Interventions
DRUG:
RMP-A03 - Dose 1
DRUG:
RMP-A03 - Dose 2
DRUG:
RMP-A03 Placebo
Sponsor
Suzhou Raymon Pharmaceuticals Company, Ltd.
Collaborators
[object Object]